Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Jan 1;146(1):25–28.

Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

PMCID: PMC1488203  PMID: 1530816

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J., Hadler S. C., Margolis H. S., Alexander W. J., Hu P. Y., Judson F. N., Mares A., Miller J. K., Moyer L. A. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990 Mar 2;263(9):1218–1222. [PubMed] [Google Scholar]
  2. Coursaget P., Yvonnet B., Chotard J., Sarr M., Vincelot P., N'doye R., Diop-Mar I., Chiron J. P. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet. 1986 Nov 15;2(8516):1143–1145. doi: 10.1016/s0140-6736(86)90543-x. [DOI] [PubMed] [Google Scholar]
  3. Coursaget P., Yvonnet B., Chotard J., Vincelot P., Sarr M., Diouf C., Chiron J. P., Diop-Mar I. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol. 1987 May;22(1):1–5. doi: 10.1002/jmv.1890220102. [DOI] [PubMed] [Google Scholar]
  4. Franks A. L., Berg C. J., Kane M. A., Browne B. B., Sikes R. K., Elsea W. R., Burton A. H. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. N Engl J Med. 1989 Nov 9;321(19):1301–1305. doi: 10.1056/NEJM198911093211905. [DOI] [PubMed] [Google Scholar]
  5. Hadler S. C. Are booster doses of hepatitis B vaccine necessary? Ann Intern Med. 1988 Mar;108(3):457–458. doi: 10.7326/0003-4819-108-3-457. [DOI] [PubMed] [Google Scholar]
  6. Hadler S. C., Francis D. P., Maynard J. E., Thompson S. E., Judson F. N., Echenberg D. F., Ostrow D. G., O'Malley P. M., Penley K. A., Altman N. L. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986 Jul 24;315(4):209–214. doi: 10.1056/NEJM198607243150401. [DOI] [PubMed] [Google Scholar]
  7. Maupas P., Chiron J. P., Barin F., Coursaget P., Goudeau A., Perrin J., Denis F., Mar I. D. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet. 1981 Feb 7;1(8215):289–292. doi: 10.1016/s0140-6736(81)91908-5. [DOI] [PubMed] [Google Scholar]
  8. Maynard J. E. Hepatitis B: global importance and need for control. Vaccine. 1990 Mar;8 (Suppl):S18–S23. doi: 10.1016/0264-410x(90)90209-5. [DOI] [PubMed] [Google Scholar]
  9. Wainwright R. B., McMahon B. J., Bulkow L. R., Hall D. B., Fitzgerald M. A., Harpster A. P., Hadler S. C., Lanier A. P., Heyward W. L. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA. 1989 Apr 28;261(16):2362–2366. [PubMed] [Google Scholar]
  10. Wainwright R. B., McMahon B. J., Bulkow L. R., Parkinson A. J., Harpster A. P. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Arch Intern Med. 1991 Aug;151(8):1634–1636. [PubMed] [Google Scholar]
  11. Yvonnet B., Coursaget P., Chotard J., Sarr M., NDoye R., Chiron J. P., Diop-Mar I. Hepatitis B vaccine in infants from an endemic area: long-term anti-HBs persistence and revaccination. J Med Virol. 1987 Aug;22(4):315–321. doi: 10.1002/jmv.1890220404. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES